Interferon beta-1b in treatment-naïve paediatric patients with relapsing–remitting multiple sclerosis: Two-year results from the BETAPAEDIC study | Zendy

AI Assistant Blog Pricing

Interferon beta-1b in treatment-naïve paediatric patients with relapsing–remitting multiple sclerosis: Two-year results from the BETAPAEDIC study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.